Monday, Mar 30th
Last update08:05:22 AM GMT
Former U.S. President Bill Clinton and drugmakers Pfizer and Matrix Laboratories Ltd announced a deal on Thursday to lower the cost of treatments for patients with drug-resistant forms of HIV/AIDS.
Second-line antiretroviral therapies and a drug used to treat tuberculosis for those with drug-resistant HIV/AIDS will be made available at a reduced cost and in more convenient regimens, saving as many as hundreds of thousands of lives in the developing world.
 The abortion rate is holding steady in the US despite total and partial bans in some... |
 A New Mexico jury determined Tuesday that Meta knowingly harmed children's mental health and concealed what... | ||
 A new COVID-19 variant, BA.3.2, has been detected in 25 states, according to a recent report... |
 A Georgia judge set a $1 bond for a woman facing murder charges tied to allegations... |
